Long-Term Data On Cimzia(R) (certolizumab Pegol) For Moderate To Severe Crohn's Disease To Be Highlighted At Upcoming DDW Meeting

Links shared publicly online about this topic.

  • 1,202
    total visits

Long-Term Data On Cimzia(R) (certolizumab Pegol) For Moderate To Severe Crohn's Disease To Be Highlighted At Upcoming DDW Meeting

medicalnewstoday.com —

Studies and analyses of the Crohn's Disease (CD) treatment Cimzia® (certolizumab pegol) demonstrating new data will be exhibited at Digestive Disease Week (DDW) 2010, taking place in New Orlea

View full resource at medicalnewstoday.com

Tags: Digestion, IBD, Crohn's Disease, Crohn's Disease Medication, Disease and Condition, Cimzia, disease

  • Share

Most Recently Shared on April 30, 2010 at 11:07 pm By:

mnt_clinical MNT Clinical Trials

Long-Term Data On Cimzia(R) (certolizumab Pegol) For Moderate To Severe Crohn's Disease To Be Highlighted At Upcoming ... http://mnt.to/3BXw

2 years ago...

Reply

Retweet

Favorite

Also Shared By:

MNT Crohn's / IBD MNT Crohn's / IBD

MNT Med Conferences MNT Med Conferences

Advertisement